Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

An In-Depth Look at Billionaire Bill Ackman’s Concentrated Equity Portfolio

Renowned activist investor Bill Ackman has been removed from the list of 20 best-performing hedge fund managers in history, after his fund Pershing Square Capital Management L.P. suffered its “greatest peak-to-through decline and worst annual performance ever” in 2015. The concentrated, research-intensive, fundamental value investor lost 20.5% net of all fees last year, after scoring a 40% gain in the previous year. Our own metric pegged his stock picks’ losses at 21.7% for the year, based on the weighted average returns of his long positions in stocks with at least a $1 billion market cap, based on the size of those positions at the beginning of each quarter.

While 2015 is a year the billionaire investor would like to forget and had surely hoped to put behind him, his fund is not doing all that great in 2016 either. Nonetheless, Bill Ackman has already proven that he can generate exceptional returns for investors and he will most likely prove it again in the upcoming years. As already mentioned, Ackman holds a relatively concentrated portfolio consisting of only eight long positions, one of which significantly weighed on his fund’s performance last year. The value of the equity portfolio overseen by Pershing Square dropped to $12.46 billion from $13.95 billion in the final quarter of 2015, during which time the activist reduced his exposure to only one company. With that in mind, the following article will discuss Ackman’s top equity holdings at the end of 2015 and the performance of the companies in question.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see more details here).

Bill Ackman
Bill Ackman
Pershing Square

Let’s start off our discussion with Valeant Pharmaceuticals Intl Inc. (NYSE:VRX), which was the worst performer within Bill Ackman’s portfolio last year. Pershing Square trimmed its stake in the beleaguered drug company by 2.88 million shares during the fourth quarter, ending the year with 16.58 million units of common stock, with a portion of the stake in Valeant being sold for tax reasons. According to a newly-amended 13D filing, Ackman currently owns 30.71 million shares of Valeant Pharmaceuticals Intl Inc. (NYSE:VRX), which include 21.59 million shares of common stock and 9.12 shares underlying call options. The shares of the specialty pharmaceutical and medical device company are down by 48% over the past 12 months due to amplified political attention on drug pricing, regulatory scrutiny, criticism and attacks from short sellers, and the interruption of an important distribution arrangement. Nonetheless, the billionaire investor does not believe that the aforementioned headwinds “will permanently impair Valeant’s intrinsic value”. Andreas Halvorsen’s Viking Global increased its exposure to Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) during the December quarter by 2.80 million shares to 7.79 million shares.

Follow Bausch Health Companies Inc. (NYSE:BHC)
Trade (NYSE:BHC) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.